期刊文献+

FZD7与β-catenin在不同亚型乳腺癌中的表达意义及两者间的关系 被引量:1

Expressions and significance of FZD7 and β-catenin in different subtypes of breast cancer and the interrelationship
原文传递
导出
摘要 目的研究FZD7与β-catenin在不同亚型乳腺癌中的临床表达意义,分析两者间的关系。方法随机选取2015年2月-2016年2月在该院接受治疗的乳腺癌患者48例,分为三阴乳腺癌组11例和非三阴乳腺癌组37例。采用免疫组化染色法观察两组患者FZD7与β-catenin的表达情况。结果癌旁正常组织中未见FZD7表达,β-catenin只在乳腺和腺泡上皮细胞中表达。乳腺癌组织中FZD7在细胞膜上表达,三阴乳腺癌的阳性表达率为63.6%,非三阴乳腺癌的阳性表达率为43.2%。非三阴乳腺癌FZD7的阳性表达率较三阴性乳腺癌低(P<0.05);β-catenin在细胞膜上表达较弱,也会在细胞质和细胞核中表达。三阴乳腺癌正常表达率72.7%,非三阴乳腺癌的正常表达率为60.0%。三阴乳腺癌β-catenin异常表达率高于非三阴乳腺癌(P<0.05)结论 FZD7阳性表达,β-catenin异常表达及淋巴结转移是不同亚型乳腺癌患者的独立预后影响因素。 Objective To research the clinical expressions and significance of FZD7 and β-catenin in different subtypes of breast cancer, analyze the interrelationship. Methods From February 2015 to February 2016, 48 breast cancer patients treated in the 98th Hospital of PLA were randomly selected and divided into triple negative breast cancer group (11 patients) and non-triple negative breast cancer group (37 patients ) . Immunohistochemical staining was used to observe the expressions of FZD7 and β- eatenin in the two groups. Results FZD7 did not express in normal paracaneerous tissue, β-catenin only expressed in mammary epithelial cells and aeinar epithelial ceils. FZD7 was located in cell membrane of breast cancer tissue. The positive expression rates in triple negative breast cancer group and non-triple negative breast cancer group were 63.6% and 43.2% , respectively. The positive expression rate of FZD7 in non-triple negative breast cancer group was statistically significantly lower than that in triple negative breast cancer group ( P〈0. 05 ) . The expression of β- eatenin in cell membrane was weak, β-eatenin also expressed in cytoplasm and cell nucleus. The normal expression rates in triple negative breast cancer group and non-triple negative breast cancer group were 72. 7% and 60. 0% , respectively. The normal expression rate in triple negative breast cancer group was statistically significantly higher than that in non-triple negative breast cancer group ( P〈0. 05 ) . Conclusion Positive expression of FZDT, abnormal expression of β-catenin, and lymph node metastasis are independent influencing factors of prognosis of patients with different subtypes of breast cancer.
作者 单浩 沈娟 盛以泉 沈海英 SHAN Hao;SHEN Juan;SHENG Yi-Quan;et al.(Department of Clinical Laboratory, the 98th Hospital of PLA, Huzhou, Zhejiang 313000, China)
出处 《中国妇幼保健》 CAS 2018年第13期2942-2944,共3页 Maternal and Child Health Care of China
关键词 FZD7 乳腺癌 Β-CATENIN FZD7 Breast cancer β-catenin
  • 相关文献

参考文献10

二级参考文献135

  • 1徐兵河.复发转移乳腺癌的化学治疗[J].中国实用内科杂志,2007,27(24):1913-1916. 被引量:20
  • 2Mongkolsapaya JG. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation [J ]. Nat Struct Biol, 1999, 6 (11) : 1048-1053.
  • 3Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery [J]. Nat Rev Cancer, 2005, 5 (11): 876-885.
  • 4Bnrikhanov R, Zhao Y, Goswami A, et al. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis[J]. Cell, 2009, 138(2) : 377-388.
  • 5Naka TS. Agents on patients' colon tumors grown in seid mice ligand alone and in combination with chemotherapeutic effects of tumor necrosis factor-related apoptosis-indueing [J]. Cancer Res, 2002, 62 (20) : 5800-5806.
  • 6Ian F, Pollack ME. Ligand Leads to selective killing of glioma cells apo21/tumor necrosis factor -related apoptosis-inducing direct stimulation of apoptotic signaling by soluble[J]. Clin Cancer Res, 2001, 7(5) : 1362-1369.
  • 7Jin HY. Apo2 ligand/tumor necrosis factor-related apoptosis-indueing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival[J]. Cancer Res, 2004, 64(14): 4900-4905.
  • 8Subrata RA. Factor-related apoptosis-inducing ligand and CPT-11 by combined treatment with apo2 ligand/ tumor necrosis apoptosis induction in prostate cancer cells and xenografts [J]. Cancer Res, 2003, 63 (15) : 4713-4723.
  • 9Mitsiades CS. TRAIL/Apo2L ligand selectively inducesapoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications[J]. Blood, 2001, 98 (3) : 795-804.
  • 10Chinnaiyan AM, Prasad U, Shankar S, et al. Combined effect of tumor necrosis factor-related apoptosis- inducing ligand and ionizing radiation in breast cancer therapy[J]. Proc Natl Acad Sci U S A, 2000, 97(4): 1754-1759.

共引文献60

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部